# pleural mesothelioma stages

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline » Purpose To provide evidence-based recommendations to practicing physicians and others on the management of malignant pleural mesothelioma. Methods ASCO convened an Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary, pathology, imaging, and advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 1990 through 2017. Outcomes of interest included survival, disease-free or recurrence-free survival, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. Results The literature search identified 222 relevant studies to inform the evidence base for this guideline. Recommendations Evidence-based recommendations were developed for diagnosis, staging, chemotherapy, surgical cytoreduction, radiation therapy, and multimodality therapy in patients with ma Ascopubs.org

Analysis of survival of patients with metastatic malignant pleural mesothelioma - Andrea Billè, Lawrence Okiror, Leanne Harling, Fausto Pernazza, Alberto Muzio, Annalisa Roveta, Federica Grosso, 2021 » Aim: To report the outcomes and prognosis of patients with malignant pleural mesothelioma (MPM) who present with or develop metastases during treatment. Methods… Journals.sagepub.com

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† » Malignant pleural mesothelioma (MPM) is considered to be a relatively rare tumour. In Great Britain, the incidence in males is 3.4/100 000, in France it is 2.3/100 000 and in the Netherlands it is 3.2/100 000. In the last 10 years, the incidence of MPM has increased slightly, mainly due to the lag time of 30–50 years after exposure to asbestos and the banning of handling and importing this product in the late twentieth century. The World Health Organisation (WHO) estimates asbestos-related disease (ARD) accounts for 92 250 deaths per year globally [1]. Annalsofoncology.org